The Latest Breaking News from Morgan Stanley

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

Frasers Group suing over $900m cash demand linked to bets placed on shares in German retailer Hugo Boss

In January, foreign funds reportedly sold a net total of .6 billion worth of China equities, according to Morgan Stanley. This indicates a cautious senti...

Morgan Stanley's executive chairman, James Gorman, has sold shares worth .4 million, reflecting his confidence in the company's performance. Learn more here.

America's symptoms of decline are everywhere — and history tells us what happens if we don't change course

Asian shares mostly lower as Wall Street declines; Tokyo's Nikkei hits 30-year high. Chinese economy grew 5.2% in 2023, surpassing target. Earnings reports...

Morgan Stanley's profit takes a hit from charges, but their revenue surpasses expectations. Find out more about the bank's latest financial results.

Morgan Stanley (MS) will release its fourth-quarter earnings on January 16. The bank is expected to report marginal revenue growth over the prior-year quarter, but its EPS is expected to decline. With green shoots visible in dealmaking, should investors consider investing in the stock now? Let’s discuss what investors need…

Bitcoin was one of the main news items last week with various Bitcoin ETF’s being approved by the SEC. According to Reuters, $4.6 billion worth of Bitcoin ETF’s traded hands as of Thursday afternoon.